Yoneda Masato | Division Of Gastroenterology Yokohama City University

スポンサーリンク

概要

関連著者

もっと見る

著作論文

Efficacy of ezetimibe for the treatment of non-alcoholic steatohepatitis : An open-label, pilot study
Metastatic Tumor in the Colon from Renal Cell Carcinoma
Characteristics of small bowel injury in symptomatic chronic low-dose aspirin users : the experience of two medical centers in capsule endoscopy
INSIG2 gene rs7566605 polymorphism is associated with severe obesity in Japanese
Variations in the FTO gene are associated with severe obesity in the Japanese
Asymptomatic Hepatic Schistosomiasis Detected by Ultrasonograpy and Confirmed by Liver Biopsy
Gene expression profiling of non-alcoholic steatohepatitis using gene set enrichment analysis
Type IV collagen 7s domain is an independent clinical marker of the severity of fibrosis in patients with nonalcoholic steatohepatitis before the cirrhotic stage
Outcome of transarterial chemoembolization monotherapy, and in combination with percutaneous ethanol injection, or radiofrequency ablation therapy for hepatocellular carcinoma
Life Style-Related Diseases of the Digestive System : Gene Expression in Nonalcoholic Steatohepatitis Patients and Treatment Strategies
A PROPOSAL FOR DIFFERENTIATION BETWEEN EARLY- AND ADVANCED-STAGE AUTOIMMUNE PANCREATITIS BY ENDOSCOPIC ULTRASONOGRAPHY
Inhibition of Peroxisome Proliferator-Activated Receptor γ Promotes Tumorigenesis Through Activation of the β-Catenin/T Cell Factor (TCF) Pathway in the Mouse Intestine
Blockade of Leukotriene B_4 Signaling Pathway Induces Apoptosis and Suppresses Cell Proliferation in Colon Cancer
Measurement of spleen volume is useful for distinguishing between simple steatosis and early-stage non-alcoholic steatohepatitis
Reply to "High-sensitivity C-reactive protein and metabolic syndrome (insulin resistance syndrome) including nonalcoholic steatohepatitis"
Novel Findings for the Development of Drug Therapy for Various Liver Diseases:Liver Microsomal Triglyceride Transfer Protein Activator May Be a Possible Therapeutic Agent in Non-alcoholic Steatohepatitis
Novel Findings for the Development of Drug Therapy for Various Liver Diseases:Preface
Influence of inducible nitric oxide synthase polymorphisms in Japanese patients with non-alcoholic fatty liver disease
Factors predictive of relapse and spontaneous remission of autoimmune pancreatitis patients treated/not treated with corticosteroids
QUANTITATIVE ANALYSIS OF LOW-DOSE ASPIRIN-ASSOCIATED SMALL BOWEL INJURY USING A CAPSULE ENDOSCOPY SCORING INDEX
DISCRIMINATION BETWEEN SCLEROSING CHOLANGITIS-ASSOCIATED AUTOIMMUNE PANCREATITIS AND PRIMARY SCLEROSING CHOLANGITIS, CANCER USING INTRADUCTAL ULTRASONOGRAPHY
RISKY ENDOSCOPIC ULTRASONOGRAPHY-GUIDED FINE-NEEDLE ASPIRATION FOR ASYMPTOMATIC RETROPERITONEAL TUMORS
A simple clinical scoring system using ferritin, fasting insulin, and type IV collagen 7S for predicting steatohepatitis in nonalcoholic fatty liver disease
Induction of microsomal triglyceride transfer protein expression is a candidate mechanism by which ezetimibe therapy might exert beneficial effects in patients with nonalcoholic steatohepatitis
Efficacy of Lactobacillus casei treatment on small bowel injury in chronic low-dose aspirin users : a pilot randomized controlled study
Usefulness of endoscopic biopsy using FOXP3^+ Treg up-regulation in the duodenal papilla in the differential diagnosis between autoimmune pancreatitis and pancreatic cancer
Novel Findings for the Development of Drug Therapy for Various Liver Diseases : Liver Microsomal Triglyceride Transfer Protein Activator May Be a Possible Therapeutic Agent in Non-alcoholic Steatohepatitis
Inhibition of Peroxisome Proliferator-Activated Receptor γ Promotes Tumorigenesis Through Activation of the β-Catenin/TCF Pathway in the Mouse Intestine
Novel Findings for the Development of Drug Therapy for Various Liver Diseases : Preface
Platelet count for predicting fibrosis in nonalcoholic fatty liver disease
Association between type 2 diabetes genetic susceptibility loci and visceral and subcutaneous fat area as determined by computed tomography
Thrombocytopenia is more severe in patients with chronic hepatitis C than in patients with nonalcoholic fatty liver disease
Genetic variations in the CYP17A1 and NT5C2 genes are associated with a reduction in visceral and subcutaneous fat areas in Japanese women
Computed tomography analysis of the association between the SH2B1 rs7498665 single-nucleotide polymorphism and visceral fat area
Association of variations in the FTO, SCG3 and MTMR9 genes with metabolic syndrome in a Japanese population
Polymorphisms in NRXN3, TFAP2B, MSRA, LYPLAL1, FTO and MC4R and their effect on visceral fat area in the Japanese population
Association between obesity and polymorphisms in SEC16B, TMEM18, GNPDA2, BDNF, FAIM2 and MC4R in a Japanese population
Screening of 336 single-nucleotide polymorphisms in 85 obesity-related genes revealed McKusick-Kaufman syndrome gene variants are associated with metabolic syndrome
Blockade of Leukotriene B4 Signaling Pathway Induces Apoptosis and Suppresses Cell Proliferation in Colon Cancer
Plasma free choline is a novel non-invasive biomarker for early-stage non-alcoholic steatohepatitis : A multi-center validation study
Association of polymorphisms in GCKR and TRIB1 with nonalcoholic fatty liver disease and metabolic syndrome traits
NUDT3 rs 206936 is associated with body mass index in obese Japanese women
noninvasive scoring systems in patients with nonalcoholic fatty liver disease with normal alanine aminotransferase levels

もっと見る

スポンサーリンク